Publications
Carnevale J, Gropper AB, Agnew-Blais J, Mimiaga MJ, Mhango A, Bail R, Ngoma M. Knowledge base and caretaker-child communication about HIV in peri-urban schoolchildren of Lusaka, Zambia. AIDS care. 2011. PMID: 21293994
Mookherjee S, Chou CL. Bedside teaching of clinical reasoning and evidence-based physical examination. Medical education. 2011. PMID: 21486342
Cerone MA, Burgess DJ, Naceur-Lombardelli C, Lord CJ, Ashworth A. High-throughput RNAi screening reveals novel regulators of telomerase. Cancer research. 2011. PMID: 21531765
Soon CW, Algazi AP, Cha EN, Webb EM, Daud AI. NRAS-mutant melanoma: response to chemotherapy. Archives of dermatology. 2011. PMID: 21576590
Leong SP, Gershenwald JE, Soong SJ, Schadendorf D, Tarhini AA, Agarwala S, Hauschild A, Soon CW, Daud A, Kashani-Sabet M. Cutaneous melanoma: a model to study cancer metastasis. Journal of surgical oncology. 2011. PMID: 21480247
Soon CW, Algazi AP, Cha EN, Webb EM, Daud AI. NRAS-mutant melanoma: response to chemotherapy. Archives of dermatology. 2011. PMID: 21576590
Greenberg S, Stopeck A, Rugo HS. Systemic treatment of early breast cancer--a biological perspective. Journal of surgical oncology. 2011. PMID: 21480257
Kapadia D, Sadikovic A, Vanloubbeeck Y, Brockstedt D, Fong L. Interplay between CD8α+ dendritic cells and monocytes in response to Listeria monocytogenes infection attenuates T cell responses. PloS one. 2011. PMID: 21559416
Spassov DS, Ahuja D, Wong CH, Moasser MM. The structural features of Trask that mediate its anti-adhesive functions. PloS one. 2011. PMID: 21559459
Ai WZ, Kohrt HE, Timmerman J, Hwang J, Hsu FJ, Czerwinski DD, Taidi B, Levy R. Prolonged disease-free survival and overall survival with CVP alternating with fludarabine in advanced follicular lymphoma. American journal of hematology. 2011. PMID: 21538469
Rubenstein JL, Treseler PA, Stewart PJ. Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011. PMID: 21519022
Espinoza AM, Venook AP. Lactic acidosis and colon cancer: oncologic emergency? Clinical colorectal cancer. 2011. PMID: 21855042
Kelley RK, Venook AP. Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? Clinical colorectal cancer. 2011. PMID: 21859557
Kelley RK, Venook AP. Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? Clinical colorectal cancer. 2011. PMID: 21859557
Geyer FC, de Biase D, Lambros MB, Ragazzi M, Lopez-Garcia MA, Natrajan R, Mackay A, Kurelac I, Gasparre G, Ashworth A, Eusebi V, Reis-Filho JS, Tallini G. Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biology. Breast cancer research and treatment. 2011. PMID: 21509527
Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Annals of internal medicine. 2011. PMID: 21502649
Logan AC, Yank V, Stafford RS. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records. Annals of internal medicine. 2011. PMID: 21502649
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Annals of internal medicine. 2011. PMID: 21502651
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Annals of internal medicine. 2011. PMID: 21502651
Dedes KJ, Wilkerson PM, Wetterskog D, Weigelt B, Ashworth A, Reis-Filho JS. Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations. Cell cycle (Georgetown, Tex.). 2011. PMID: 21487248